04/02/2026
👉*Launch of Vaicmo-SP Tablets*
A clear expression of quality, science and trust
Today, we are proud to announce the launch of *Vaicmo-SP* a balanced, clinically aligned formulation of *Aceclofenac, Paracetamol and Serratiopeptidase* developed to meet the evolving needs of modern pain and inflammation management.
For us, a product is never just a formulation; it is a reflection of our scientific mindset, quality-driven approach and long-term commitment to healthcare excellence.
👉*Vaicmo-SP* is the outcome of this philosophy—where efficacy, consistency and trust come together.
Developed under stringent manufacturing standards and well-defined quality processes, this product strengthens our ongoing effort to offer healthcare professionals a reliable and dependable therapeutic option.
👇*Vaicmo-SP*
A solution designed to meet today’s clinical expectations while shaping the healthcare standards of tomorrow.
